Utah Medical Products (NASDAQ:UTMD) Stock Passes Above 200 Day Moving Average – Here’s What Happened

Utah Medical Products, Inc. (NASDAQ:UTMD) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $59.23 and traded as high as $64.24. Utah Medical Products shares last traded at $63.73, with a volume of 12,256 shares traded.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Utah Medical Products in a report on Wednesday, January 21st. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has a consensus rating of “Sell”.

Utah Medical Products Price Performance

The company has a market cap of $203.94 million, a PE ratio of 18.31 and a beta of 0.34. The business has a 50-day moving average of $59.29 and a 200 day moving average of $59.23.

Utah Medical Products (NASDAQ:UTMD) last announced its earnings results on Thursday, January 29th. The medical instruments supplier reported $0.80 EPS for the quarter. The business had revenue of $9.04 million during the quarter. Utah Medical Products had a net margin of 29.30% and a return on equity of 9.60%.

Utah Medical Products Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, April 3rd. Investors of record on Tuesday, March 17th will be given a dividend of $0.31 per share. The ex-dividend date is Tuesday, March 17th. This represents a $1.24 annualized dividend and a yield of 1.9%. Utah Medical Products’s payout ratio is 35.63%.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. O Shaughnessy Asset Management LLC grew its stake in shares of Utah Medical Products by 2.3% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 14,903 shares of the medical instruments supplier’s stock valued at $834,000 after acquiring an additional 337 shares during the period. First Horizon Advisors Inc. lifted its holdings in Utah Medical Products by 159.7% during the second quarter. First Horizon Advisors Inc. now owns 587 shares of the medical instruments supplier’s stock valued at $33,000 after purchasing an additional 361 shares in the last quarter. Everett Harris & Co. CA boosted its position in shares of Utah Medical Products by 2.1% in the second quarter. Everett Harris & Co. CA now owns 17,478 shares of the medical instruments supplier’s stock worth $995,000 after purchasing an additional 362 shares during the period. Comerica Bank increased its stake in shares of Utah Medical Products by 435.6% in the third quarter. Comerica Bank now owns 541 shares of the medical instruments supplier’s stock worth $34,000 after purchasing an additional 440 shares in the last quarter. Finally, Cardinal Capital Management raised its position in shares of Utah Medical Products by 1.9% during the 4th quarter. Cardinal Capital Management now owns 24,836 shares of the medical instruments supplier’s stock valued at $1,394,000 after purchasing an additional 459 shares during the period. Institutional investors own 69.60% of the company’s stock.

About Utah Medical Products

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).